Development and field testing of primary care screening tools for harms of long-term opioid therapy continuation and tapering to discontinuation: a study protocol.
internal medicine
pain management
substance misuse
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
07 10 2021
07 10 2021
Historique:
entrez:
8
10
2021
pubmed:
9
10
2021
medline:
4
11
2021
Statut:
epublish
Résumé
Despite calls for screening tools to help providers monitor long-term opioid therapy (LTOT) harms, and identify patients likely to experience harms of discontinuation, such screening tools do not yet exist. Current assessment tools are infeasible to use routinely in primary care and focus mainly on behaviours suggestive of opioid use disorder to the exclusion of other potential harms. This paper describes a study protocol to develop two screening tools that comprise one integrated instrument, We will develop the screening tools, SET1 and SET2, concurrently. Tool development will be done in stages: (1) comprehensive literature searches to yield an initial item pool for domains covered by each screening tool; (2) qualitative item analyses using interviews, expert review and cognitive interviewing, with subsequent item revision, to yield draft versions of each tool; and (3) field testing of the draft screening tools to assess internal consistency, test-retest reliability and convergent and discriminant validity. Ethical approval was obtained from the Institutional Review Boards of Stanford University and the University of California, San Francisco for the VA Palo Alto Health Care System, and the VA San Francisco Healthcare System, respectively. Findings will be disseminated through peer-reviewed manuscripts and presentations at research conferences.
Identifiants
pubmed: 34620670
pii: bmjopen-2021-053524
doi: 10.1136/bmjopen-2021-053524
pmc: PMC8499315
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e053524Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Pain. 2019 Feb;20(2):181-191
pubmed: 30243859
Pain Med. 2011 May;12(5):740-6
pubmed: 21481167
J Pain. 2014 Nov;15(11):1148-1155
pubmed: 25179150
J Grad Med Educ. 2013 Sep;5(3):353-6
pubmed: 24404294
J Ambul Care Manage. 2004 Jan-Mar;27(1):70-83
pubmed: 14717468
J Consult Psychol. 1960 Aug;24:349-54
pubmed: 13813058
Pain. 2007 Jul;130(1-2):144-56
pubmed: 17493754
Drug Alcohol Depend. 2003 Dec 11;72(3):279-86
pubmed: 14643945
J Pain Res. 2013 Sep 05;6:663-81
pubmed: 24049456
Mayo Clin Proc. 2015 Jun;90(6):828-42
pubmed: 26046416
Ann Intern Med. 2018 Oct 2;169(7):448-455
pubmed: 30208405
Qual Health Res. 2002 Jul;12(6):855-66
pubmed: 12109729
Subst Abus. 2018;39(2):152-161
pubmed: 28929914
N Engl J Med. 2019 Jun 13;380(24):2285-2287
pubmed: 31018066
Pharmacoepidemiol Drug Saf. 2020 Mar;29(3):252-269
pubmed: 31851773
PLoS One. 2018 May 2;13(5):e0196390
pubmed: 29718951
JAMA. 2016 Apr 19;315(15):1624-45
pubmed: 26977696
Am Fam Physician. 2016 Jun 15;93(12):982-90
pubmed: 27304767
Pain Med. 2019 Mar 1;20(3):429-433
pubmed: 30496540
J Clin Epidemiol. 2015 Sep;68(9):1085-92
pubmed: 25962972
Pain Med. 2019 Apr 1;20(4):724-735
pubmed: 30690556
Pain. 2007 Sep;131(1-2):38-47
pubmed: 17250963
Pharmacoepidemiol Drug Saf. 2018 May;27(5):526-534
pubmed: 28879660
Pain Med. 2013 Jul;14(7):1021-31
pubmed: 23614929
J Subst Abuse Treat. 2015 Mar;50:67-75
pubmed: 25534151
Gen Hosp Psychiatry. 2017 Jul;47:29-35
pubmed: 28807135
Complement Ther Med. 2018 Aug;39:8-13
pubmed: 30012396
Int Rev Neurobiol. 2018;139:129-157
pubmed: 30146045
Br J Gen Pract. 2007 Feb;57(535):144-51
pubmed: 17263931
BMJ Open. 2019 Nov 12;9(11):e034039
pubmed: 31722956
J Pain. 2017 Mar;18(3):308-318
pubmed: 27908840
Pain. 2019 Jul;160(7):1586-1593
pubmed: 30839428
J Rehabil Res Dev. 2016;53(1):127-36
pubmed: 27006339
J Gen Intern Med. 2011 Sep;26(9):958-64
pubmed: 21347877
JAMA Netw Open. 2019 Dec 2;2(12):e1917228
pubmed: 31825504
Addict Behav. 2013 May;38(5):2154-7
pubmed: 23454878
Br J Community Nurs. 2004 Mar;9(3):110-4
pubmed: 15028996
J Subst Abuse Treat. 2013 Mar;44(3):256-63
pubmed: 22898042
Pain Med. 2016 Oct;17(10):1838-1847
pubmed: 27207301
J Clin Epidemiol. 2013 Jul;66(7):710-8
pubmed: 23566375
J Gen Intern Med. 2018 Jun;33(6):818-824
pubmed: 29380212
Pain Rep. 2017 Mar 06;2(2):e589
pubmed: 29392205
Implement Sci. 2021 Jul 2;16(1):67
pubmed: 34215286
Pharmacy (Basel). 2020 Aug 20;8(3):
pubmed: 32825483
Clin Chem. 2004 Jul;50(7):1118-25
pubmed: 15142978
Med Care. 2007 May;45(5 Suppl 1):S12-21
pubmed: 17443114
Pain Physician. 2012 Jul;15(3 Suppl):S1-65
pubmed: 22786448
J Gen Intern Med. 2011 Sep;26(9):965-71
pubmed: 21562923
Am J Drug Alcohol Abuse. 1987;13(3):293-308
pubmed: 3687892
Med Care. 2007 May;45(5 Suppl 1):S22-31
pubmed: 17443115
Drug Alcohol Depend. 2020 Nov 1;216:108294
pubmed: 33007702
J Gen Intern Med. 2009 Jun;24(6):733-8
pubmed: 19418100
Qual Health Res. 2016 Nov;26(13):1753-1760
pubmed: 26613970
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Subst Use Misuse. 2017 Nov 10;52(13):1701-1711
pubmed: 28622067